These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31674205)

  • 41. Risk of cancer among relatives of patients with glioma.
    O'Neill BP; Blondal H; Yang P; Olafsdottir GH; Sigvaldason H; Jenkins RB; Kimmel DW; Scheithauer BW; Rocca WA; Bjornsson J; Tulinius H
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):921-4. PubMed ID: 12223439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic and prognostic molecular markers in common adult gliomas.
    Rivera AL; Pelloski CE
    Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial.
    Boele FW; Klein M; Verdonck-de Leeuw IM; Cuijpers P; Heimans JJ; Snijders TJ; Vos M; Bosma I; Tijssen CC; Reijneveld JC;
    J Neurooncol; 2018 Mar; 137(1):191-203. PubMed ID: 29236238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review.
    IJzerman-Korevaar M; Snijders TJ; de Graeff A; Teunissen SCCM; de Vos FYF
    J Neurooncol; 2018 Dec; 140(3):485-496. PubMed ID: 30377935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal diagnosis by using two-marker studies.
    Smith GT; Isidoro F; Thie JA; Hubner KF
    Radiology; 2003 Jul; 228(1):292-3; author reply 293. PubMed ID: 12832591
    [No Abstract]   [Full Text] [Related]  

  • 47. Central nervous system.
    Adamson DC; Rasheed BA; McLendon RE; Bigner DD
    Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls.
    Wrensch M; Lee M; Miike R; Newman B; Barger G; Davis R; Wiencke J; Neuhaus J
    Am J Epidemiol; 1997 Apr; 145(7):581-93. PubMed ID: 9098174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The morphology and differential diagnosis of neuroglial heterotopias and related tumors].
    Shelekhova KV; Sokolova IA; Kazakov DV; Michal M
    Arkh Patol; 2009; 71(4):56-9. PubMed ID: 19824435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is mortality due to primary malignant brain and other central nervous system tumors decreasing?
    Gittleman H; Kromer C; Ostrom QT; Blanda R; Russell J; Kruchko C; Barnholtz-Sloan JS
    J Neurooncol; 2017 Jun; 133(2):265-275. PubMed ID: 28470430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis.
    Goldschmidt N; Zamir L; Poperno A; Kahan NR; Paltiel O
    J Am Board Fam Med; 2016 Nov; 29(6):702-709. PubMed ID: 28076253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central nervous system tumors.
    Jacques G; Cormac O
    Handb Clin Neurol; 2013; 112():931-58. PubMed ID: 23622303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic neuropathology of tumors of the central nervous system.
    Rodriguez FJ; Giannini C
    Handb Clin Neurol; 2012; 104():77-107. PubMed ID: 22230437
    [No Abstract]   [Full Text] [Related]  

  • 54. [Performance evaluation of hospital claims database for the identification of incident central nervous system tumors compared with a cancer registry in Gironde, France, 2004].
    Coureau G; Baldi I; Savès M; Jaffré A; Barat C; Gruber A; Loiseau H; Kostrzewa A; Servas V; Salamon R; Gilleron V
    Rev Epidemiol Sante Publique; 2012 Aug; 60(4):295-304. PubMed ID: 22704681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.
    Hollender A; Kvaloy S; Nome O; Skovlund E; Lote K; Holte H
    Ann Oncol; 2002 Jul; 13(7):1099-107. PubMed ID: 12176790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myelomatous Involvement of the Central Nervous System.
    Paludo J; Painuly U; Kumar S; Gonsalves WI; Rajkumar V; Buadi F; Lacy MQ; Dispenzieri A; Kyle RA; Mauermann ML; McCurdy A; Dingli D; Go RS; Hayman SR; Leung N; Lust JA; Lin Y; Gertz MA; Kapoor P
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):644-654. PubMed ID: 27624224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
    van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
    Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN.
    Piel C; Pouchieu C; Carles C; Béziat B; Boulanger M; Bureau M; Busson A; Grüber A; Lecluse Y; Migault L; Renier M; Rondeau V; Schwall X; Tual S; ; Pierre L; Baldi I
    Environ Int; 2019 Sep; 130():104876. PubMed ID: 31344646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort.
    Schlehofer B; Siegmund B; Linseisen J; Schüz J; Rohrmann S; Becker S; Michaud D; Melin B; Bas Bueno-de-Mesquita H; Peeters PH; Vineis P; Tjonneland A; Olsen A; Overvad K; Romieu I; Boeing H; Aleksandrova K; Trichopoulou A; Bamia C; Lagiou P; Sacerdote C; Palli D; Panico S; Sieri S; Tumino R; Sanchez MJ; Rodriguez L; Dorronsoro M; Duell EJ; Chirlaque MD; Barricarte A; Borgquist S; Manjer J; Gallo V; Allen NE; Key TJ; Riboli E; Kaaks R; Wahrendorf J
    Allergy; 2011 Nov; 66(11):1434-41. PubMed ID: 21726235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
    Lukas RV; Stupp R; Gondi V; Raizer JJ
    Oncology (Williston Park); 2018 Jan; 32(1):17-22. PubMed ID: 29447417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.